Huo Yong: Reasonable use of proton pump inhibitors to help balance the benefits and risks of antithrombotic drug therapy

Oral antithrombotic drug treatment is an important measure for the prevention and treatment of cardiovascular diseases

"Heart Concern": The latest "Expert Consensus on Prevention and Treatment of Oral Antithrombotic Drug-related Gastrointestinal Injury" is the crystallization of the collective wisdom of experts in the field of cardiovascular and digestion in China.

Professor Yong Huo: First of all, I want to emphasize the background of the clinical use of oral antithrombotic drugs

With the deepening of basic and clinical research and the continuous accumulation of evidence-based medicine, as well as the development and clinical application of various drugs, we have found that antithrombotic drugs play a pivotal role in the prevention and treatment of thromboembolic diseases

"Heart Concern": What do you think will be the important impact on the treatment of cardiovascular diseases in China after the consensus is released?

Professor Yong Huo: "Expert Consensus on Prevention and Treatment of Gastrointestinal Injury Related to Oral Antithrombotic Drugs" is the result of the joint efforts of multidisciplinary experts.

"Heart Concern": In the process of using proton pump inhibitors (PPI) with antithrombotic drugs, what issues should we pay attention to?

Professor Yong Huo: PPI is a revolutionary drug to reduce gastrointestinal bleeding.

PPI also plays an important role in the prevention and treatment of gastrointestinal injury and even bleeding associated with antithrombotic drugs

In addition, we also need to pay attention to the effect of the metabolic pathway of PPI on the efficacy of antithrombotic drugs

Expert introduction

Huo Yong

Chief Physician, Professor, Doctoral Supervisor of Peking University First Hospital, concurrently President of the World Chinese Cardiovascular Physicians Association, President of the Asian Society of Cardiology, Vice President of the World Chinese Physician Association, Chairman of the Certification Working Committee of the Chinese Chest Pain Center, and Chinese Medical Doctor Association Chairman of the Chest Pain Professional Committee, Vice President of the Cardiovascular Physician Branch of the Chinese Medical Doctor Association, Vice Chairman of the China Cardiovascular Health Alliance, and Dean of the Suzhou Industrial Park Cardiovascular Health Research Institute